Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Understanding the guidelines for treating HIV disease

M J Chesebro1, W D Everett

  • 1University of Alabama School of Medicine, Huntsville, USA.

American Family Physician
|February 11, 1998
PubMed
Summary

Updated guidelines for human immunodeficiency virus (HIV) treatment emphasize monitoring viral load and CD4+ counts. Multi-drug antiretroviral therapy shows significant clinical improvement in HIV-1 infected patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-risk human papillomavirus testing of women with cytological low-grade squamous intraepithelial lesions.

Journal of lower genital tract disease·2015
Same author

Follow-up of the minimally abnormal Pap smear.

American family physician·1997
Same author

Using serum markers in the early diagnosis of myocardial infarction.

American family physician·1997
Same author

Atypical squamous cells of undetermined significance (ASCUS): do the guidelines actually help?

The Journal of family practice·1997
Same author

A cost-benefit analysis of colposcopy for cervical squamous intraepithelial lesions found on Papanicolaou smear.

Archives of family medicine·1996
Same author

Cost-effectiveness of hepatitis B virus immunization.

JAMA·1996

Area of Science:

  • Medical Science
  • Infectious Diseases
  • Virology

Background:

  • The International AIDS Society-USA established treatment guidelines for human immunodeficiency virus (HIV) infection in 1996.
  • These guidelines have undergone recent updates to reflect advancements in HIV management.
  • Monitoring key biomarkers is crucial for effective HIV care.

Purpose of the Study:

  • To summarize the updated guidelines for treating HIV infection.
  • To highlight the importance of monitoring viral load and CD4+ lymphocyte levels.
  • To underscore the benefits of multi-drug antiretroviral therapy.

Main Methods:

  • Guidelines were developed by a panel of experts convened by the International AIDS Society-USA.
  • Monitoring of quantitative plasma HIV-1 RNA concentration (viral load) and CD4+ lymphocyte levels is central to the guidelines.
  • Antiretroviral treatment regimens include nucleoside analogs, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors.

Main Results:

  • Quantitative plasma HIV-1 RNA concentration (viral load) and CD4+ lymphocyte levels are essential for monitoring disease progression.
  • These markers guide the initiation, effectiveness monitoring, and modification of antiretroviral treatment.
  • Multi-drug therapy has demonstrated measurable clinical outcome improvements in HIV-1 infected patients.

Conclusions:

  • Updated guidelines provide a framework for optimal HIV management.
  • Effective HIV treatment relies on regular monitoring of viral load and immune status.
  • Combination antiretroviral therapy is a cornerstone for improving clinical outcomes in HIV-1 infection.

Related Experiment Videos